Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, Beishuizen A, Cepelova M, Ceppi F, Fernandez-Teijeiro A, Fosså A, Georgi TW, Hjalgrim LL, Hraskova A, Leblanc T, Mascarin M, Pears J, Landman-Parker J, Prelog T, Klapper W, Ramsay A, Kluge R, Dieckmann K, Pelz T, Vordermark Det al.(2025) Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial JAMA Oncol(in press) DOI 10.1001/jamaoncol.2024.5636, PubMed 39745682
Kimby EK, Schär S, Pirosa MC, Vanazzi A, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJMJ, Krasniqi F, Voegeli M, Novak U, Zander T, Bersvendsen H, Mamot C, Mingrone W, Stathis A, Dirnhofer S, Hayoz S, Østenstad B, Zucca E(2025) Six-month Rituximab-Lenalidomide regimen in advanced untreated Follicular Lymphoma: SAKK 35/10 Trial 10-year Update Blood Adv(in press) DOI 10.1182/bloodadvances.2024014840, PubMed 39883948
Ludvigsen LUP, Åsberg A, Spetalen S, Sørensen MD, Hamilton-Dutoit S, Gramkow AM, Christiansen CF, Kro GB, Thomsen MK, Ulrichsen SP, Pedersen RM, Holte H, Thiesson HC, Bjerre A, D'Amore F, Dahle DO, Jespersen B, Jensen-Fangel S, Reisæter AV(2025) Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - an observational cohort study from Norway and western Denmark Am J Transplant(in press) DOI 10.1016/j.ajt.2025.01.035, PubMed 39884653